S. 2986: American Medicine Safety and Security Act

The American Medicine Safety and Security Act seeks to implement specific employment and operational policies at the Food and Drug Administration (FDA) to enhance the safety and security of drugs and medical devices. The key components of the bill are:

1. Employment Restrictions

The bill prohibits individuals who are nationals of designated "foreign countries of concern," specifically the People's Republic of China, Russia, or Iran, from being employed by or providing services for the FDA. This is intended to prevent potential conflicts of interest or security risks related to national safety.

2. Reporting Obligations

Any FDA employee or individual working with the agency must disclose if they have an immediate family member (parent, sibling, or child) who is a national of a foreign country of concern. Failure to report this information can lead to immediate termination of employment or service agreements.

3. Limitation on Subsequent Employment

Individuals who have been employed by the FDA will not be allowed to work for organizations based in foreign countries of concern for a ten-year period following their employment at the FDA. This provision applies to both existing employees, who must agree to this condition to keep their jobs, and new employees hired after the law takes effect.

4. Restricted Access to Sensitive Information

FDA employees or contractors involved in reviewing applications for drugs or medical devices will have limited access to classified information. Specifically, they will not be able to access sensitive information unless they comply with certain criteria, such as not having immediate family connections to a foreign country of concern or not having worked for an entity in those countries previously.

5. Definitions

The bill provides specific definitions for key terms, clarifying what constitutes a "foreign country of concern" and defining "immediate family" for the purposes of the reporting requirement.

6. Objective of the Bill

The overall goal is to strengthen the integrity and security of the FDA's workforce and processes, ensuring that sensitive health-related information is protected from potential foreign influence or exploitation.

Relevant Companies

• PFE - Pfizer Inc.: As a major pharmaceutical company, Pfizer could be impacted by restrictions on FDA employees who may influence drug approvals and regulatory processes.
• JNJ - Johnson & Johnson: This company may be affected due to FDA interactions concerning drug and device approvals, potentially influencing their operations and strategic decisions.
• MRK - Merck & Co., Inc.: Similar to others in the industry, Merck may face implications regarding access to regulatory processes impacting their products.